Fresenius Medical Care buys Spectra Laboratories
This article was originally published in Clinica
Executive Summary
Fresenius Medical Care North America has bought Spectra Laboratories, the largest independent provider of end-stage renal disease laboratory services in the US. Spectra currently provides clinical laboratory testing services to more than 30,000 patients. Fresenius Medical Care's existing laboratory business, LifeChem, offers testing services to some 61,000 patients.